Trials / Completed
CompletedNCT04246554
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketorolac | Oral ketorolac for pain control following ACL reconstruction surgery |
| DRUG | Oxycodone-Acetaminophen | Oral oxycodone-acetaminophen for post-operative pain control |
Timeline
- Start date
- 2019-05-21
- Primary completion
- 2020-10-09
- Completion
- 2021-01-01
- First posted
- 2020-01-29
- Last updated
- 2021-12-21
- Results posted
- 2021-12-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04246554. Inclusion in this directory is not an endorsement.